# A Cross-over Study Examining the Bioequivalence of 3 Test Formulations to a Reference Formulation of Alectinib (RO5424802) in Healthy Volunteers

> **NCT02074553** · PHASE1 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 97 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Ro542-4802/F03 (Reference)
- **DRUG:** Ro542-4802/F07 (Test)
- **DRUG:** Ro542-4802/F08 (Test)
- **DRUG:** Ro542-4802/F14 (Test)

## Key facts

- **NCT ID:** NCT02074553
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2023-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02074553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02074553, "A Cross-over Study Examining the Bioequivalence of 3 Test Formulations to a Reference Formulation of Alectinib (RO5424802) in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02074553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*